Publications

Explaining Gene Therapy in thalassaemia (2020)

Explaining Gene Therapy in thalassaemia (2020)

The second educational brochure from the TIF’s ‘Gene Therapy’ booklet series, providing an in-depth view of how this revolutionary therapy works in patients with β-thalassaemia major.
COVID-19 & Haemoglobin Disorders: A Classification of Risk Groups & Other Considerations (2020)

COVID-19 & Haemoglobin Disorders: A Classification of Risk Groups & Other Considerations (2020)

A TIF-compiled document aiming to provide a division of risk levels for thalassaemia and SCD patients with regards to the ongoing COVID-19 pandemic.
WEEKLY UPDATE: Developing Vaccinations & Therapeutic Drugs for COVID-19

WEEKLY UPDATE: Developing Vaccinations & Therapeutic Drugs for COVID-19

All the latest updates of TIF’s Vaccinations & Therapeutic Drugs Guide for COVID-19 gathered in one single document.
Gene Therapy in β-thalassaemia and other haemoglobin disorders (2019)

Gene Therapy in β-thalassaemia and other haemoglobin disorders (2019)

An educational leaflet aiming to strengthen the knowledge and understanding of patients with thalassaemia and other haemoglobin disorders across the world on most aspects relevant to gene therapy.
Bone Marrow Transplantation in β-thalassaemia (2018)

Bone Marrow Transplantation in β-thalassaemia (2018)

An educational leaflet with important information for β-thalassaemia patients on hematopoietic stem cell transplantation (HSCT), more commonly known as bone marrow transplantation (BMT).
Bouton retour en haut de la page
Fermer
Fermer